Section Arrow
NVO.NYSE
- Novo-Nordisk A/S
Quotes are at least 15-min delayed:2026/03/09 20:36 EDT
Regular Hours
Last
 39.78
+1.2 (+3.11%)
Day High 
39.88 
Prev. Close
38.58 
1-M High
51.09 
Volume 
23.80M 
Bid
39.66
Ask
39.75
Day Low
38.495 
Open
39.19 
1-M Low
35.85 
Market Cap 
171.48B 
Currency 美元 
P/E 10.75 
%Yield 7.55 
10-SMA 38.2 
20-SMA 43.49 
50-SMA 51.29 
52-W High 82.57 
52-W Low 35.85 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
23.03/20.74
Enterprise Value
290.42B
Balance Sheet
Book Value Per Share
6.80
Cash Flow
Cash Flow Yield
0.11
Income Statement
Total Revenue
309.06B
Operating Revenue Per Share
6.83
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.5099+0.1247+32.37%-- 
PFEPfizer26.81-0.24-0.89%19.84PE
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
MRKMerck & Co117.11+1.32+1.14%15.9PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.